Highlights and Quick Summary
- Other current assets for the quarter ending June 30, 2023 was $5.44 Million (a -50.56% decrease compared to previous quarter)
- Year-over-year quarterly Other current assets decreased by -46.1%
- Annual Other current assets for 2022 was $9.58 Million (a 64.61% increase from previous year)
- Annual Other current assets for 2021 was $5.82 Million (a 54.28% increase from previous year)
- Annual Other current assets for 2020 was $3.77 Million (a 2870.87% increase from previous year)
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Other current assets of Dyne Therapeutics, Inc.
Most recent Other current assetsof DYN including historical data for past 10 years.Interactive Chart of Other current assets of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Other current assets for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $5.44 | $11.0 | – | – | – |
| 2022 | $9.58 | $10.09 | $6.1 | $21.3 | $9.58 |
| 2021 | $5.82 | $17.13 | $25.71 | $3.98 | $5.82 |
| 2020 | – | – | $3.77 | $0.23 | $3.77 |
| 2019 | – | – | – | – | $0.13 |
| 2018 | – | – | – | – | $0.03 |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology